-29.9%
BITO vs MRNA
+511.3%
-541.2%
-54.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.5% | -2.2% | -0.2% | -2.3% |
| 7D | +2.9% | +5.5% | -2.6% | +2.6% |
| 30D | +22.6% | +158.7% | -136.1% | +10.5% |
| 3M | +24.7% | +182.1% | -157.5% | +9.3% |
| 6M | +7.5% | +151.8% | -144.4% | -4.2% |
| YTD | -10.8% | +393.6% | -404.4% | -29.2% |
| 1Y | -29.9% | +499.5% | -529.4% | -45.7% |
| All | -29.9% | +511.3% | -541.2% | -45.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling